Publication | Closed Access

The impact of anticancer activity upon Beta vulgaris extract mediated biosynthesized silver nanoparticles (ag-NPs) against human breast (MCF-7), lung (A549) and pharynx (Hep-2) cancer cell lines

NanoparticlesNanomedicineHuman BreastEngineeringMedicineBeta Vulgaris ExtractSilver NanoparticlesNano-drug DeliveryTumor TargetingPharmacologyRadiation OncologyTumor Microenvironment